News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Jasmina Ivanova

Articles by Jasmina Ivanova

Latest Updated Articles

19 Real-world Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Talazoparib-Treated Patients With HER2-Negative, Locally Advanced or Metastatic Breast Cancer and Germline BRCA Mutations
Published: April 18th 2022 | Updated:

Trending on CancerNetwork

Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC

Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC

Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC

Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups

Perioperative Enfortumab Vedotin Combo Has Potential as SOC in Cisplatin-Ineligible MIBC

© 2025 MJH Life Sciences^®

All rights reserved.